Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine
Clinical trial NCT00513968 · COMPLETED
Trial details
- NCT number
- NCT00513968
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2010-04-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.